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Novel poly{(lactic acid)-co-[(glycolic acid)-alt-(L-glutamic acid)]}-g-monomethyl poly(ethylene glycol) (PLGGE) micelles were 
prepared and used as carriers for anti-tumor drug delivery. Three PEGylated PLGG copolymers (PLGGE2000, PLGGE1100 and 
PLGGE500) were characterized by XRD, TG and DSC. The critical micelle concentrations (CMCs) of the amphiphilic copoly-
mers were 1.04, 0.55 and 0.13 μg/mL, respectively. The TEM, AFM and DLS measurements revealed that the micelles were ho-
mogeneous spherical nanoparticles with the diameters ranged from 50 to 150 nm when THF was used as solvent in the prepara-
tion of the micelles. Interestingly, extended cylindrical micelles were obtained using CHCl3 as solvent. The micelles could trap 
doxorubicin (DOX) in the core with the highest drug loading content up to 23.7%. The mean diameter of drug loaded micelles 
was much bigger than that of blank micelles. The in vitro drug release of the micelles was diffusion-controlled release within the 
first 36 h and initial burst release was not obvious. However, after 36 h, the release rate in pH 5.0 was faster than that in pH 7.4 
due to the degradation. The PLGGE micelles were nontoxic to both NIH 3T3 fibroblasts and HepG2 cells. The in vitro cytotoxi-
city against HepG2 cells demonstrated that the drug loaded micelles exhibited high inhibition activity to cancer cells. CLSM ob-
servation of HepG2 cells showed that DOX released from the micelles could be delivered into cell cytoplasm and cell nuclei. 
PLGGE micelles are potential promising carriers for anti-tumor drug delivery.  
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Doxorubicin (DOX) is a promising broad-spectrum anti-
cancer drug with high potency against many types of solid 
cancers including breast cancer, lung cancer, liver cancer, 
etc. [1,2], and it has achieved remarkable success in early 
clinical trials [3]. Despite DOX’s potency, its application 
was largely hampered because of its poor water-solubility 
[4], stability, drug resistance and a number of side effects to 
normal tissues [5,6]. One way to resolve these problems is 
to encapsulate the drug into biodegradable polymer micelles. 
As promising antitumor drug carriers, polymer micelles 
have attracted much attention for the delivery of drug due to 
their excellent properties such as high solubilization of hy-
drophobic drugs (avoiding phagocytic and renal clearance) 
[7], controllable drug release, selectively targeting delivery 
[8], low toxicity in normal cells and high stability of drugs 
in vitro and in vivo. Polymeric micelles with size ranged 
from 10 to 100 nm could also avoid the clearance of reticu-
loendothelial system (RES) [9] and passively accumulated 
in tumor tissue via the enhanced permeability and retention 
(EPR) effect [10,11].  
Long circulation time in bloodstream is the prerequisite 
for self-assembly micelles as drug carriers. Poly(ethylene 
glycol)(PEG) is a biocompatible, non-toxic and water-  
soluble biomaterial. Micelles containing PEG grafts or 
blocks would form a hydrated shell on the surface of mi-
celles. It could effectively inhibit protein adsorption, sec-
ondary aggregation and reticuloendothelial system uptake, 
thus leading to higher stability and longer circulation times 
[12], its uptake by cells [13], and prolonged plasma half- 
lives [14]. Hydrophobic segments of micelles were critical 
in drug loading content and efficiency and release rate [15]. 
Poly (L-lactic acid) (PLLA) was widely studied as hydro-
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phobic segments for its good biodegradability and low im-
munogenicity [16,17]. However, the application of the PLA 
is limited due to the high crystallinity, and the acidic degra-
dation product of PLA would cause acute inflammation. 
Morpholine-2,5-dione derivative and its copolymers were 
good drug carriers with biocompatibility, biodegradability, 
non-acid degradation products and no crystallinity [18–20]. 
Copolymers of L-lactide and morpholine-2,5-dione deriva-
tive combined the properties of both PLLA and poly [mor-
pholine-2,5-dione] [19,21]. As hydrophobic segments in 
micelles, they would not only alleviate the inflammation 
response and high crystallinity, but also improve the drug 
release performance. The synthesis of poly{(lactic acid)- 
co-[(glycolic acid)-alt-(L-glutamic acid)]} (PLGG) was 
firstly reported by Deng et al. [21]. Guan et al. [22–24] 
synthesized PLGG-b-PEG-b-PLGG, PLGG(-paclitaxel)-b- 
PEG-b-PLGG (-paclitaxel) and PLGG(-glucose)-b-PEG-b- 
PLGG(-glucose) triblock copolymers, which self-assembled 
micelles. To our knowledge, there were rare reports on mi-
celles composed of graft copolymer poly{(lactic acid)-co- 
[(glycolic acid)-alt-(L-glutamic acid)]}-g-monomethyl poly- 
(ethylene glycol) (PLGGE) for DOX delivery. 
In this paper, we synthesized a series of graft copolymer 
poly{(lactic acid)-co-[(glycolic acid)-alt-(L-glutamic acid)]}- 
g-monomethyl poly(ethylene glycol) (PLGGE). The proper-
ties of PLGGE copolymers were characterized by XRD, TG 
and DSC. The PLGGE polymers self-assembled micelles 
with PLGG as core and mPEG as shell. Anti-tumor drug 
doxorubicin was encapsulated in the micelles (Scheme 1). 
The properties of PLGGE micelles including critical micelle 
concentration (CMC), morphology and size were explored. 
Especially, the morphology of PLGGE micelles prepared 
using different organic solvent was investigated by AFM. 
The in vitro release profiles of drug loaded micelles were 
investigated in two different buffered solutions (pH 7.4 and 
5.0). The NIH 3T3 fibroblasts and liver cancer cells HepG2 
were incubated with blank micelles to evaluate the cytotox-
icity. The drug loaded micelles were incubated with HepG2 





Scheme 1  The schematic self assembly of drug loaded PLGGE micelles. 
1  Materials and methods 
1.1  Materials 
γ-benzyl L-glutamate (BLG), L-Lactide (LLA), stannous 
octanoate (SnOct2), pyrene (>99%), palladium on activated 
charcoal (Pd/C, 10%), dicyclohexylcarbodiimide (DCC), 
dimethylaminopyridine (DMAP), and monomethyl poly 
(ethylene glycol) of MW=2000, 1100 and 500 (mPEG) were 
purchased from Sigmae Aldrich. Doxorubicin hydrochloride 
(>99%, Sigmae Aldrich) was deprotonated by dissolving in 
water (2 mg/mL) and adjusted to pH 9.6 to obtain the hy-
drophobic DOX [25]. Dulbecco’s modified Eagle’s medium 
(DMEM), 100× mycillin, and fetal bovine serum were used 
for cytotoxicity test. Dichloromethane, chloroform, toluene 
and dimethyl sulfoxide (DMSO) were dried by refluxing 
over CaH2 and distilled before use. All other solvents (ob-
tained from Kelong Chemical Co. Chengdu, China) were 
ACS grade and used as-received.  
1.2  Synthesis and characterizations of the PLGGE 
graft copolymer  
The synthesis of (3s)-3-benzoxylcarbonylethyl-morpholine- 
2,5-dione (BEMD) was performed by the reaction steps as 
described in the literature [19]. The poly[LA-co-(Glc-alt- 
Glu(Bz)), 92:8] (PLGBG) was synthesized by ring-opening 
copolymerization of both BEMD (100 mg, 0.361 mmol) and 
LLA (598 mg, 4.151 mmol) using SnOct2 as catalyst, i.e. 
8% mole content of BEMD in feed. The PLGBG (92:8) was 
deprotected by the catalytic (Pd/C) hydrogenation reaction 
to yield poly[LA-co-(Glc-alt-Glu)] ( PLGG, 5K) containing 
pendant carboxyl groups. A series of mPEG2000, 
mPEG1100 and mPEG500 were respectively linked to the 
pendant carboxyl groups of PLGG (92:8, 5K) in the pres-
ence of DCC and DMAP to yield the PLGG (92:8, 5K)-g- 
mPEG (PLGGE). 1H NMR (a Bruker AV-400 MHz, CDCl3, 
δ, ppm): 2.19–2.76 (CH2CH2COO), 4.61 (NHCH), 4.84 
(COCH2), 6.05(NH), 5.16 (CH of lactic acid), 1.58 (CH3 of 
lactic acid), 3.38 (–OCH3 of the pendant mPEG), 3.65 
(–OCH2CH2– of the pendant mPEG). 
The TGA of the mPEG, PLGG and PLGGE samples was 
performed on a NETZSCH instrument (Germany). Ap-
proximate 3–4 mg of sample was heated from 35 to 600°C 
at a heating rate of 10°C/min under a nitrogen purge of 30 
mL/min. 
The differential scanning calorimetric (DSC) experi-
ments were performed on a TA System Q100 under nitro-
gen at a flow rate of 50 mL/min. The samples of PLGG and 
PLGGE copolymers were heated from −90 to 170°C at a 
heating rate of 10°C/min.  
X-ray diffractometry (XRD) measurements were carried 
out on a Rigaku D/max-2500 X-ray diffractometer with a 
CuKα source ( γ = 1.78897 nm; 50 kV; 100 mA) in the 2θ 
range of 7°–40° at a scanning speed of 2.0°/min.  
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1.3  Preparation and characterization of micelles  
For preparation of PLGGE micelles, the copolymer was 
dissolved in chloroform or THF, and then dropped into the 
deionized water in a beaker under stirring. The beaker was 
opened to air with agitation for 24 h. The residual chloro-
form or THF was removed by rotation evaporator.  
Pyrene was used as a fluorescence probe to measure the 
critical micelle concentration (CMC) of PLGGE. The 
PLGGE solutions with concentration from 1×10−8 to 1.0 
mg/mL were shook with pyrene (6.0×10−7 mol/L) at 37°C 
overnight. The fluorescence spectra of each sample under 
excitation at λem=395 nm with a scan rate of 240 nm/min 
were obtained using a Hitachi F-7000 Spectrofluorometer 
(Japan) at 25°C. The CMC was estimated by plotting the 
pyrene fluorescence intensity ratio I338/I334 against the loga-
rithm of the micelle concentration. 
The particle size, size distribution, and morphology of 
micelles were characterized by dynamic light scattering 
(DLS, Malvern Zetasizer Nano ZS) instrument, atomic 
force microscopy (AFM, ECLIPSE Ti-U MFP-3D-BIO) 
and transmission electron microscopy (TEM, JEM-100CX 
(JEOL)), respectively.  
1.4  Preparation of drug loaded micelles  
The DOX loaded micelles were prepared as following [26]: 
DOX was dissolved in THF (1.1 mg/mL) containing DMSO 
(3 drops) and stirred for 10 min, and subsequently dropped 
to 10 mg/mL of PLGGE under stirring. The mixture was 
opened to air under stirring overnight. After filtration 
through a syringe filter (pore size: 450 nm) to remove the 
DOX aggregates, the unincorporated DOX was eliminated 
by ultrafiltration using regenerated cellulose centrifuge fil-
ters (MWCO 3.5 kD, USA) through centrifugation (3800 
r/min). The product was freeze-dried. The amount of en-
trapped DOX was measured by UV absorbance at 485 nm 
(UV-Vis, Lambda 650). The drug loading content (DLC, %) 
and encapsulation efficiency (EE, %) were calculated by the 
following equation: 
DLC = (weight of DOX in micelles)/ 
    (weight of drug loaded micelles)×100%,  (1) 
 EE = (weight of DOX in micelles)/ 
        (weight of DOX in feed) ×100%. (2) 
1.5  In vitro DOX release profile 
The in vitro release of DOX from PLGGE micelles suspen-
sion (1.0 mL, DLC 10 wt%) in MWCO 3500 Da dialysis 
bags was determined in a vial containing 25 mL of phos-
phate buffered saline (PBS, 0.01 mol/L) with pH 7.4 and 5.0. 
The vials were put in a shaking bed with the shaking rate of 
120 r/min at 37°C. At scheduled time intervals, 5 mL of the 
dialysis buffer was taken out and replaced with another 
equal volume of fresh PBS. The measurement of the DOX 
concentration in the dialysate was performed by measuring 
the absorbance at 485 nm with a UV-Visible spectropho-
tometer (Lambda 650). The release was carried out in trip-
licate and the average was showed. As control, the release 
profile of free DOX was tested using the same method. 
1.6  Cell culture 
Liver cancer cell HepG2 and NIH 3T3 fibroblasts were re-
spectively cultured in Dulbecco’s Modified Eagle’s Medi-
um (DMEM) supplemented with 10% fetal bovine serum 
(Chengdu Halibio Co., Ltd., China), 100 IU/mL penicillin 
and 100 μg/mL streptomycin at 37°C in a humidified at-
mosphere of 5% CO2. Subsequently, HepG2 and 3T3 cells 
were respectively plated at a cell density of 5×103 cells per 
well in a 96-well plate in 100 μL of medium and incubated 
for another 24 h. The resulted cell suspension was used in 
the following experiments. 
1.7  Safety of micelles 
The cytotoxicity of blank micelles was evaluated by 
co-culturing the micelles with HepG2 and NIH 3T3. The 
two cell lines were cultured for 24 h in 96-well plates 
(5×103 cells per well) in Dulbecco’s Modified Eagle’s Me-
dium (DMEM) supplemented with 10% fetal bovine serum, 
100 IU/mL penicillin and 100 μg/mL streptomycin. The 
culture media were replaced by media containing different 
concentrations of PLGGE2000 micelles. After 48 h incuba-
tion, the cell viability was evaluated by MTT assay.  
1.8  Cytotoxicity of micelles 
HepG2 cells were seeded onto 96-well plates at 5×103 cells 
per well and incubated for 24 h (37°C, 5% CO2). Then the 
culture medium was replaced with 100 μL of the fresh cul-
ture medium containing free DOX or DOX loaded micelles 
at different concentrations. The cells were further incubated 
for 12, 24, 48 and 72 h. Then, 10 μL of MTT solution (5 
mg/mL, in PBS, pH 7.4) was added to each well. After in-
cubated for 4 h, the solution containing unreacted MTT was 
carefully removed from each well. The blue formazan crys-
tals formed were dissolved with 100 μL of DMSO. The 
absorbance at 492 nm was measured using a Thermo scien-
tific MK3. The cell viability was calculated by the follow-
ing formula [27]: Cell viability % = (Isample/Icontrol)×100%, 
where Isample and Icontrol represent the fluorescence intensity 
determined for cells treated with different micelles and for 
control cells (nontreated), respectively. 
1.9  Confocal laser scanning microscopy (CLSM) 
CLSM was used to examine the intracellular distribution of 
DOX. HepG2 cells were cultured at 5×103 cells per well on 
35 mm diameter glass dishes for 24 h. The culture medium 
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was replaced with fresh medium containing free DOX or 
drug loaded micelles. After being incubated for 3 and 24 h, 
the cells were washed three times with PBS (pH 7.4) to re-
move DOX or DOX loaded micelles outside the cells. Flu-
orescence intensity was measured by CLSM (Leica TCP 
SP5) with excitation at 485 nm and emission at 595 nm for 
DOX. 
2  Results and discussion 
2.1  Properties of the PLGGE copolymers 
The amphiphilic PLGGE graft copolymers with different 
mPEG side chain lengths were successfully synthesized.  
The Molecular weight of mPEG were 2000, 1100 and   
500, respectively. Thus, the PLGGE2000, PLGGE1100  
and PLGGE500 were selected for the following studies. 
The X-ray diffraction (XRD) analysis of the three 
PLGGE polymers is illustrated in Figure 1. The spectrum of 
PLGGE2000 showed two strongest diffraction peaks at 2θ 
=19.2° and 23.2° which were the typical crystal of mPEG 
[28]. The PLGGE2000 also presented relative lower dif-
fraction peaks at 2θ =16.8°. As for PLGGE500, two strong-
est diffraction peaks appeared at 2θ=16.8° and 19.2°, mainly 
due to the semi-crystallization of PLGG polymer backbone. 
Interestingly, the crystal structure of the PLGGE1100 was 
different from that of the PLGGE2000 and PLGGE500, and 
only a stronger and rather broader diffraction peak in about 
2θ =10°–25° region was observed (Figure 1(b)). It indicated 
that the conjugation of mPEG with PLGG suppressed the 
crystallization of both PLGG and mPEG.  
The thermal stability of the PLGGE was evaluated using 
TGA. Thermogravimetric analysis (Figure 2) revealed that 
the onset of thermal degradation for each sample occurred 




Figure 1 XRD spectra of PLGGE2000 (a), PLGGE1100 (b) and 
PLGGE500 (c). 
 
Figure 2  TGA curves of mPEG2000 (a), PLGGE2000 (b), PLGGE1100 
(c), PLGGE500 (d) and PLGG (e). 
weight loss starting from 240.6 to 340°C while that of 
mPEG2000 from 383.6 to 430°C. For three PLGGE graft 
copolymers, the thermal degradation appeared to occur in 
two steps. The tendency was similar. The first weight losses 
of three PLGGE copolymers starting from about 233°C 
were assigned to the decomposition of the polymer back-
bone (PLGG), while the subsequent weight losses at about 
387°C were attributed to the decomposition of the grafted 
mPEG chains [28]. Furthermore, the PLGGE2000, 
PLGGE1100 and PLGGE500 lost 51.88%, 72.56% and 
84.17% of their weights. When the temperature increased 
from 387°C, the weight loss of PLGGE2000, PLGGE1100 
and PLGGE500 decreased from 44.35%, 23.00% to 11.23%. 
These results were in good agreement with the mass ratio of 
mPEG in the copolymers. Additionally, at 500°C or higher, 
all the weight losses were higher than 98%, it indicated the 
complete decomposition of the copolymers. 
The DSC thermograms of PLGGE are presented in Fig-
ure 3 and the calorimetric data are summarized in Table 1. 
PLGG was a semi-crystalline polymer showing a Tg of 51°C 
and Tm of 141°C (Figure 3(a)), whereas mPEG2000 was 
highly crystallized, showing a Tm of 56°C (not shown). Al-
most the same Tg and Tm for PLGGE500, PLGGE1100 and 
PLGGE 2000 were observed at approximate 23°C and 
136°C, respectively. It was mainly attributed to the PLGGE 
containing the same polymer backbone (PLGG). For the 
PLGGE2000, another strong melting peak appeared at 
52.4°C, and its Hm value increased remarkably, reflecting 
the high crystallinity. This was caused by the side chain of 
mPEG2000. Table 1 showed a slight decrease of Tm from 
56°C (in mPEG2000) to 52.4°C in PLGGE2000 copolymer, 
the graft of mPEG disturbed the crystallization process 
[28,29]. With the increase of mPEG content, the Hc value 
of the cold crystallization peak of PLGGE copolymers de-
creased. The Hc value of PLGGE500 at 77.6°C was seven 
times stronger than that of PGGE1100 at 85.1°C, while the  
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Figure 3  DSC thermograms of PLGG (a), PLGGE500 (b), PLGGE1100 
(c) and PLGGE2000 (d). 
Table 1  Thermal properties of PLGG, PLGGE500, PLGGE1100 and 
PLGGE2000 
 Tg (°C) Tm (°C) ∆Hm (J/g) Tc (°C) −∆Hc (J/g) 
PLGG 51.13 141.10 4.12   
PLGGE500 23.48 134.80 22.03 77.66 19.4 
PLGGE1100 22.73 138.17 21.09 85.13 2.73 
PLGGE2000 21.65 52.44;135.97 36.12;14.83   
 
cold crystallization peak of PLGGE2000 was not observed. 
PLGGE500, PLGGE1100 and PLGGE2000 were semi- 
crystalline copolymers. The results were strongly supported 
by XRD study (Figure 1). It has been reported that the 
semi-crystalline polymers were advantageous compared to 
the high crystalline polymers when used as a drug delivery 
carrier due to its high mobility, high permeability and low 
influence on tissue growth and inflammation [30]. 
2.2  Characterization of micelles 
The three amphiphilic PLGGE copolymers self-assembled 
the micelles with hydrophobic core and hydrophilic shell. 
Pyrene was widely used as a fluorescence probe to test the 
CMCs. As shown in Table 2, the CMC values of PLGGE- 
2000, PLGGE1100 and PLGGE500 were 1.04×10−3, 0.55× 
10−3 and 0.30 ×10−3 mg/mL, respectively. It was found that 
the graft copolymers with a larger hydrophobic backbone 
(PLGG) had a relatively lower CMC. This result implied 
that the micelles had high stability upon strong dilution in 
the bloodstream. Furthermore, the decrease in the number of 
EO units resulted in a small decrease of the CMC, which is 
consistent with those reported for copolymers [31,32]. The 
reason was that the decrease of the hydrophilic chain length 
increased the aggregating tendency of the hydrophobic 
PLGG segment, which led to a more stable micellar struc-
ture with smaller CMC value. 
The formation of the self-assembled PLGGE2000, 
PLGGE1100 and PLGGE500 micelles was further con-
firmed by AFM measurement as shown in Figure 4 and Ta-
ble 3. When the micelles were prepared using THF as sol-
vent (Figure 4(a1), (b1) and (c1)), the three micelles clearly 
showed a homogeneous spherical shape and a narrow size 
distribution. The mean diameters of the micelles formed by 
PLGGE2000, PLGGE1100 and PLGGE500 were 50, 90, 
and 150 nm, respectively. However, when micelles were 
prepared from CHCl3 as solvent, the cylindrical micelles 
(Figure 4(b2) and (c2)) were observed apart from a spheri-
cal shape of PLGGE2000 micelles (Figure 4(a2)). That 
meant the formation of cylindrical micelles became easier 
instead of spherical with the decrease of the hydrophilic 
mPEG chain length. These results were in agreement with 
the conclusions that previously reported [33,34]. Such tran-
sitions were due to that the increase of the hydrophilic chain 
length induced greater interfacial curvature [34]. A balance 
between interfacial tension and chain stretching led to an 
equilibrium domain morphology and size. Thus, the mor-
phology of PLGGE micelles was controlled via the prepara-
tion method and the chain length of mPEG. In addition, the 
diameters of micelles prepared from CHCl3 were almost 
consistent with those from THF (Table 3). 
Table 2  Properties of blank and DOX loaded PLGGE micelles 
Samples Mn
 a) (×103) CMC (μg/mL) b) Diameter (nm) 
c) 
DLC (%)d) EE (%)e) 
Blank micelle DOX-micelle 
PLGGE2000 10.3 1.04 50 105 12.2 32.3 
PLGGE1100 8.7 0.55 78 122 17.9 36 
PLGGE500 6.3 0.13 141 220 23.7 40.2 
a) Molecular weight obtained from a Waters 510 GPC data (THF as eluent); b) determined using pyrene as a fluorescence probe; c) determined by DLS; 
d) drug loading content; e) encapsulation efficiency. 
Table 3  Physicochemical parameters of PLGGE self-assemble micelles in water 
Samples THF diameter (nm)a)  Morphologyb) CHCl3 diameter (nm)
a)  Morphologyb) 
PLGGE2000 50 S 50 S 
PLGGE1100 90 S 85 C 
PLGGE500 150 S 150 C 
a) Diameter determined by AFM; b) morphology observed by AFM; S, spherical; C, cylinder. 
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Figure 4  AFM images of PLGGE2000 (a), PLGGE1100 (b) and PLGGE500 (c) micelles. (a1), (b1) and (c1) were prepared using THF as solvent. (a2), (b2) 
and (c2) were prepared using CHCl3 as solvent. The mean diameters of PLGGE2000, PLGGE1100 and PLGGE500 were 50, 90 and 150 nm, respectively. 
2.3  Characterization of empty and DOX loaded  
micelles 
The size distributions and morphology of the empty and 
DOX loaded PLGGE micelles were determined by DLS and 
TEM. The mean diameters of the three drug loaded micelles 
were always larger than those of corresponding empty mi-
celles. DLS (Figure 5) results showed that all self-aggre- 
gates had a uniform size distribution. The mean diameter 
(105 nm) of the drug loaded micelles was 2.1 times larger 
than that of drug-free micelles (50 nm). It indicated that the 
enlargement of the particles size was caused by the encap-
sulated DOX. The increased particle size might be attribut-
ed to interactions between DOX and copolymers, further to 
affect the aggregation of the amphiphic copolymers, thus 
led to the tremendous differences in average size [35]. TEM 
(Figure 6) images showed that both the empty and DOX  
loaded micelles were well dispersed as individual micelles 
with uniform spherical shape. The results revealed a narrow 
size distribution with the mean diameters of 38 and 75 nm, 
respectively. The diameters of spheres observed by TEM 
were slightly smaller than those by DLS (Figure 5). The 
reason for this difference was that the mean diameters de-
termined by DLS represented their hydrodynamic diameters 
after the hydration of mPEG segments, whereas those de-
termined by TEM reflected the dried micelles [36,37].  
2.4  Drug loading and in vitro drug release 
The drug loading content and efficiency of the three micelles 
are presented in Table 2. The drug loading content and en-
capsulation efficiency of the micelles were as high as 23.7% 
and 40.2%. Both drug loading content and encapsulation 
efficiency increased with decreasing the side chain length of  
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Figure 5  Size distribution of blank (a) and DOX loaded (b) PLGGE2000 
micelles determined by DLS. The mean diameters of blank and DOX 
loaded micelles were 50 and 105 nm, respectively. 
 
Figure 6  TEM images of blank (a) and DOX loaded (b) PLGGE2000 
micelles, the micelles showed unimodal distribution with the mean diame-
ters of 38 and 75 nm, respectively. 
mPEG.  
The drug release of PLGGE micelles in two different 
buffered solutions (pH 7.4 and 5.0) are shown in Figure 7. 
At the same pH value, the accumulated release rate of 
PLGGE gradually decreased with decreasing the mPEG 
side chain length. At pH 7.4, the drug release rates of 
PLGGE 2000, PLGGE 1100 and PLGGE 500 micelles after  
 
Figure 7  In vitro release profiles of DOX from micelle formulations 
(PLGGE2000, 1100 and 500) at pH 7.4 and 5.0. 
168 h were 60%, 31% and 19%, respectively. Because of 
the shorter hydrophilic side chain length of mPEG, the per-
meation of water into polymeric cores was more difficult, 
thus led to the lower diffusion of DOX through the copoly-
mers. Interestingly, at the different pH values (7.4 and 5.0), 
the effects of pH value on the release of DOX from same 
polymer micelles were not observed in the first 36 h, mainly 
due to a slow diffusion-controlled release through the pol-
ymer matrix. After 36 h, however, the DOX release from 
micelles at pH 5.0 was much faster than that at pH 7.4. The 
faster release of DOX in acidic conditions could be ex-
plained as the following reasons: (1) hydrogen bonds were 
possibly formed between the polymer and DOX at pH 7.4, 
which could be broken at pH 5.0 [38]; and (2) the degrada-
tion of hydrophobic PLGG (micellar core) was faster at pH 
5.0 than at pH 7.4 [39]. The degradation rate of the PLGG 
was also faster than that of PLA. This was mainly attributed 
to the disruption of the crystallinity caused by the incorpo-
ration of L-glutamate residues and the improvement of hy-
drophilicity due to mPEG segment. For the tumor-targeted 
DOX delivery, it was important for pH-sensitive releasing 
behavior to result faster release at acidic conditions in the 
solid tumor [40]. As decreasing the chain length of mPEG, 
the effects of pH value on the DOX-release became no more 
obvious (such as PLGGE500). This could be attributed to 
the decrease of water solubility of PLGGE. Additionally, no 
initial burst releases of PLGGE micelles at pH 5.0 and 7.4 
were observed, which meant that DOX was largely en-
trapped in the hydrophobic cores of the micelles.  
2.5  Safety of empty micelles 
As drug carriers, it is necessary to evaluate the cytotoxicity 
of the empty micelles using cell viability assay [41]. The 
cell lines of HepG2 and NIH 3T3 cells were incubated with  
blank micelles. Figure 8 shows the cell viability of PLGGE- 
2000 micelles with 48 h incubation. The cell viability of the 
 Yu Z X, et al.   Chin Sci Bull   November (2012) Vol.57 No.31 4001 
micelles with different concentrations in HepG 2 cells was 
comparable to those of blank control. However, the cell 
viability of the micelles in NIH 3T3 cells increased with 
increasing the concentration of the micelles, and it was even 
higher than 100%. It implied that the high concentration of 
micelles was in favor of cell proliferation. These results 
demonstrated that the polymeric micelles were non-toxic. 
2.6  Intracellular drug distribution 
CLSM was employed to study the cellular uptake and in-
tracellular distribution of DOX loaded micelles in the liver 
cancer HepG2 cells and the images are shown in Figure 9. 
After 3 h incubation, the strong red fluorescence of free 
DOX was observed not only in cell cytoplasm but also nu-
clei, whereas that of DOX loaded micelles was observed   
 
Figure 8  The cytotoxicity of PLGGE2000 blank micelles to HepG2 and 
3T3 cells after incubated for 48 h. 
 
 
Figure 9  CLSM-images of HepG2 cells after incubated with free DOX for 3 h (a1)–(a3) and 24 h (b1)–(b3), and with DOX loaded PLGGE2000 micelles 
for 3 h (c1)–(c3) and 24 h (d1)–(d3). (a1)–(d1) The morphologies of cells visualized in the phase-contrast mode; (a2)–(d2) red fluorescence images from 
excitation of DOX; (a3)–(d3) the overlay of fluorescence channel with bright field. 
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only in in the cytoplasm rather than the cell nuclei. When 
the incubation period was elongated to 24 h, the red fluo-
rescence of free DOX was observed only in the nuclei and no 
red fluorescence was detected in the cytoplasm. However, 
after DOX loaded micelles were incubated for 24 h, the 
intensity of red fluorescence obviously increased in cyto-
plasm. These results showed that the intracellular distribu-
tion of the DOX loaded micelles was different from that of 
free DOX, and it also demonstrated that PLGGE2000 mi-
celle could effectively transport DOX into the cytoplasm, as 
similarly reported in [25,42]. The internalization mechanism 
of free DOX was that low molecular weight DOX entered 
cells via direct permeation through the cellular membrane, 
while the drug loaded micelles were generally internalized 
through an endocytosis pathway and localized in endocytic 
compartments (e.g. endosomes and subsequently lysosomes) 
[42–45]. For those micelles trapped in endosomes/     
lysosomes, DOX in PLGGE2000 micelles entered the nu-
clei much slower than free DOX, as indicated in LCSM 
measurement. However, DOX in micelles could eventually 
be delivered into the nuclei to exert its cytotoxicity [46] and 
inhibit the replication of DNA replication. This was demon-
strated by the following cytotoxicity results as shown in 
Figure 10. 
2.7  In vitro Cytotoxicity test of the drug loaded micelles 
The morphologies of the HepG2 cells after 48 h incubation 
with the samples are shown in Figure 10. Free and encapsu-
lated DOX could reduce the numbers of tumor cells obvi-
ously. Most cells attached and stretched well in empty mi-
celles (Figure 10(b)), almost like control (Figure 10(a)). All 
the cells exposed to free DOX (10 μg/mL) detached and 
shrank to spheres (Figure 10(c)). Namely, the free DOX 
could kill nearly all the tumor cells. For the sample of drug 
loaded micelles, some cells detached and some stretched  
 
 
Figure 10  The morphologies of HepG2 cells after 48 h incubation with: 
(a) cell culture plate as control, (b) blank micelles of PLGGE2000, (c) free 
DOX and (d) DOX loaded micelles. The concentrations of micelle and 
DOX were 1000 and 10 μg/mL, respectively. 
well with the same concentration of DOX (Figure 10(d)). 
This was because the cell endocytosis of the drug loaded 
micelles into endosomes/lysosomes was influenced by their 
scaled diameter, and the DOX release from the micelles was 
relatively slow, thus, both cell morphological changes and 
alterations in cell numbers confirmed that the anti-tumor 
effect of drug loaded micelles was inferior to that of free 
DOX.  
The MTT assay was carried out for quantitative analysis 
in the cytotoxicity of the drug loaded micelles to the HepG2 
cells (Figure 11). The quantitative results were coincident to 
the results in Figure 10. As the drug concentration increased 
from 0.25 to 20 μg/mL, the cell viabilities of the two sam-
ples decreased obviously (Figure 11(a)). When the DOX 
concentration was 10 μg/mL, free DOX could kill almost all 
the cells, while only 40% of HepG2 cells were killed by the 
DOX loaded micelles. In the meanwhile, the IC50 (DOX 
concentrations that kill 50% of cells) of drug loaded mi-
celles (17.3 μg/mL) was about 6 times higher than that of 
free drug (3.0 μg/mL) after 48 h incubation. This was due to 
that free DOX could be readily transported into nuclei by 
the diffusion mechanism, whereas the micelles were inter-
nalized by endocytosis to release the loaded drugs, and the 
drug diffused through the endocytic compartment membrane 
to reach the nuclei [44]. Interestingly, to the cell viabilities of 
free DOX, there was less decrease when the concentration 
 
 
Figure 11  The inhibition effects of HepG2 cells. (a) With various con-
centrations of the drug after 48 h incubation with DOX loaded micelles and 
free DOX (the concentration of DOX: 0.25–20 μg/mL); (b) after 12, 24, 48 
and 72 h incubation with DOX loaded micelles and free DOX (the concen-
tration of DOX:10 μg/mL).  
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was more than 10 μg/mL. As shown in Figure 11(b), with 
the incubation time increasing, the cell viabilities of both 
free DOX and drug loaded micelles decreased obviously. 
Hence, higher drug concentration and longer incubation 
time will cause lower cell viability. It meant the cytotoxicity 
of the DOX loaded micelles was dependent on the concen-
tration of the drug and incubation time. 
3  Conclusions 
A series of PLGGE graft copolymers were fabricated. The 
properties of PLGGE2000, PLGGE1100 and PLGGE500 
were characterized by XRD, TG and DSC. The copolymers 
self-assembled micelles with shell-core structure with the 
mean diameter ranged from 50 to 150 nm. The CMCs of the 
micelles varied from 1.04 to 0.13 μg/mL. When the micelles 
were prepared using THF as solvent, the micelles displayed 
unimodal size distribution and homogeneous spherical 
shape. To PLGGE1100 and PLGGE500 copolymers, the 
extended cylindrical micelles were observed when micelles 
prepared from CHCl3 as solution. The anti-tumor drug DOX 
was entrapped in the micelles and the highest drug loading 
content and efficiency were 23.7% and 40.2%, respectively. 
The release rate of DOX from the micelles was a slow dif-
fusion-controlled release within the first 36 h and initial 
burst release was not observed. After 36 h, the release rate 
in pH 5.0 was faster than that in pH 7.4 due to the degrada-
tion-controlled sustained release. The in vitro cytotoxicity 
assay of DOX loaded micelles against HepG2 cells showed 
that DOX could be efficiently released from the micelles to 
inhibit the proliferation of cancer cells. CLSM studies 
showed that the released DOX could be effectively deliv-
ered into cells. PLGGE micelles are promising carriers for 
anti-tumor drug delivery.  
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